Katherine Karakoula | Cancer Research | Innovative Research Award

Innovative Research Award

Katherine Karakoula
Affiliation University of Wolverhampton
Country United Kingdom
Scopus ID 8300564600
Documents 15
Citations 250
h-index 10
Subject Area Cancer Research
Event World Biophotonics Research Awards
ORCID 0000-0001-5484-5453

Katherine Karakoula of the University of Wolverhampton has established a recognized academic profile within the field of cancer research through scholarly publications, citation impact, and interdisciplinary scientific contributions. Her work reflects sustained engagement in biomedical investigations related to cancer biology, diagnostic methodologies, and translational research applications. The present article provides an overview of her academic profile, research contributions, publication record, scientific influence, and suitability for recognition under the Innovative Research Award category of the World Biophotonics Research Awards.[1]

Abstract

This article summarizes the academic achievements and research profile of Katherine Karakoula in the field of cancer research. Drawing upon publication metrics, citation performance, and scholarly engagement, the profile highlights contributions to biomedical science and cancer-related investigations. The analysis emphasizes research productivity, scientific influence, and the relevance of the nominee’s work within contemporary cancer research and biophotonics-related interdisciplinary domains.[1]

Keywords

Cancer Research; Biomedical Science; Translational Medicine; Oncology; Research Impact; Scientific Publications; Citation Analysis; Biophotonics Applications; Academic Excellence; Innovative Research.

Introduction

Innovation in cancer research remains essential for advancing diagnostic capabilities, therapeutic interventions, and patient outcomes. Researchers contributing to these developments play a significant role in expanding scientific understanding and facilitating translational applications. Katherine Karakoula has contributed to this research landscape through peer-reviewed publications and collaborative scientific efforts that support ongoing advancements in oncology and related biomedical disciplines.[2]

Research Profile

Based at the University of Wolverhampton, Katherine Karakoula has developed an academic portfolio characterized by research activity within cancer research and associated biomedical sciences. Her documented scholarly record includes fifteen indexed publications, approximately 250 citations, and an h-index of 10, indicating measurable academic influence and engagement within the scientific community.[1]

  • Research specialization in cancer-related biomedical investigations.
  • Peer-reviewed scholarly publication record.
  • Demonstrated citation impact within the research community.
  • Participation in interdisciplinary scientific collaborations.

Research Contributions

The nominee’s research contributions are associated with advancing knowledge in cancer biology and related translational applications. Her publications contribute to scientific understanding of disease mechanisms, diagnostic approaches, and evidence-based methodologies relevant to oncology. Such work supports broader efforts aimed at improving clinical decision-making and patient-centered healthcare outcomes.[2]

  • Contribution to cancer-focused biomedical research.
  • Support for translational and clinically relevant investigations.
  • Development of evidence-based scientific knowledge.
  • Promotion of interdisciplinary research collaboration.

Publications

The publication portfolio reflects sustained scholarly activity within cancer research. Indexed articles have contributed to citation accumulation and visibility across the scientific literature. Representative publication themes include oncology, molecular biology, diagnostic methodologies, and translational biomedical science.[1]

  1. Cancer biology and molecular mechanisms.
  2. Biomedical diagnostics and clinical applications.
  3. Translational oncology research.
  4. Interdisciplinary health science studies.

Research Impact

Research impact may be evaluated through publication productivity, citation performance, scholarly visibility, and scientific influence. With approximately 250 citations and an h-index of 10, Katherine Karakoula’s work demonstrates measurable recognition among researchers and contributes to the cumulative body of knowledge in cancer research.[1]

  • 15 indexed scholarly documents.
  • Approximately 250 citations.
  • h-index value of 10.
  • Continued contribution to oncology-related scholarship.

Award Suitability

The Innovative Research Award recognizes researchers whose work demonstrates originality, scientific rigor, and measurable impact. Based on available publication metrics, citation performance, and contributions to cancer research, Katherine Karakoula exhibits characteristics consistent with the objectives of the award. Her scholarly activities support continued innovation within biomedical science and align with the broader mission of advancing research excellence.[1][3]

Conclusion

Katherine Karakoula has established a notable research profile through sustained publication activity, scholarly citations, and contributions to cancer research. Her academic achievements demonstrate engagement with impactful scientific questions and interdisciplinary collaboration. The available evidence indicates a research trajectory aligned with the principles of innovation, academic excellence, and scientific advancement recognized by the World Biophotonics Research Awards.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Katherine Karakoula, Author ID 8300564600. Scopus. https://www.scopus.com/authid/detail.uri?authorId=8300564600
  2. Pseudomonas aeruginosa: associated pathogenesis, epidemiology, resistance mechanisms, host response and emerging treatment strategies. https://link.springer.com/article/10.1007/s00203-026-04839-0
  3. Glioblastoma Stem Cells as Targets for Emerging Precision Immunotherapies and Molecular Treatments.
    https://www.mdpi.com/2073-4409/15/9/783

Fatemeh Tajik | Cancer Biophotonics Studies | Cancer Biophotonics Award

Dr. Fatemeh Tajik | Cancer Biophotonics Studies | Cancer Biophotonics Award

Assistant Specialist at University of California Irvine Medical Center, United States

Dr. Fatemeh Tajik is an accomplished medical researcher dedicated to advancing cancer diagnostics. She earned her MD in 2021, ranking among the top 1% of her class. Since then, she has been engaged in groundbreaking research on cancer biomarkers, particularly circulating extracellular vesicle biomarkers for peritoneal carcinomatosis. Currently serving as an Assistant Specialist at the University of California, Irvine, Dr. Tajik contributes significantly to translational and clinical research, with the goal of improving patient outcomes.

Profile

ORCID

Education 🎓

Dr. Tajik completed her Doctor of Medicine (MD) in 2021. Her academic excellence placed her among the top 1% of her graduating class. Her advanced studies and research focus on cancer biomarker identification, leading to significant contributions in oncology.

Experience 🌟

From 2021 to 2023, Dr. Tajik dedicated her research to identifying novel cancer biomarkers, culminating in multiple peer-reviewed publications. In 2023, she joined the Department of Surgery at the University of California, Irvine, where she specializes in translational cancer research. Additionally, she serves as a reviewer for esteemed journals and has co-authored a book chapter, further demonstrating her expertise and commitment to the field.

Research Interests 🌿

Dr. Tajik’s research revolves around cancer biology, with a specific focus on:

  • Cancer biomarkers
  • Extracellular vesicles
  • Peritoneal carcinomatosis Her work aims to refine predictive and prognostic tools for cancer, significantly impacting early detection and treatment approaches.

Awards 🏆

Dr. Tajik has been recognized for her contributions to cancer research and innovation. She has been nominated for prestigious awards such as the Excellence in Research Award and the Best Researcher Award, highlighting her significant impact on the field.

Publications 📚

Dr. Tajik has published extensively in high-impact journals. Her notable publications include:

“Iterative Intraperitoneal Chemotherapy in Gastric Cancer Peritoneal Carcinomatosis”

  • Journal: Cancers
  • Publication Date: January 17, 2025
  • DOI: 10.3390/cancers17020289

“Regional Therapy Approaches for Gastric Cancer with Limited Peritoneal Disease”

  • Journal: Journal of Gastrointestinal Cancer
  • Publication Date: June 2024
  • DOI: 10.1007/s12029-023-00994-5

“Transformation of Chronic Lymphocytic Leukemia into Acute Mixed Phenotype Leukemia Myeloid/T Neoplasm: a Case Report”

  • Journal: SN Comprehensive Clinical Medicine
  • Publication Date: September 11, 2023
  • DOI: 10.1007/s42399-023-01567-0

“Anxiety during the COVID-19 pandemic in hospital staff: systematic review plus meta-analysis”

  • Journal: BMJ Supportive & Palliative Care
  • Publication Date: June 2023
  • DOI: 10.1136/bmjspcare-2021-003125

“A comprehensive Examination of the potential application of Chat GPT in Higher Education Institutions”

  • Type: Preprint
  • Publication Date: April 12, 2023
  • DOI: 10.36227/techrxiv.22589497.v1

“Post-COVID-19 rhinocerebral mucormycosis, a life-threatening event in the background of immunosuppressive condition: A case report”

  • Type: Preprint
  • Publication Date: January 27, 2023
  • DOI: 10.21203/rs.3.rs-2516078/v1

“Adoption of cytoreductive surgery in the management of peritoneal malignancies—Global trends”

  • Journal: Journal of Surgical Oncology
  • Publication Date: 2023
  • DOI: 10.1002/jso.27448

“Circulating exosomal microRNAs as potential prognostic biomarkers in gastrointestinal cancers: a systematic review and meta-analysis”

  • Journal: Cancer Cell International
  • Publication Date: 2023
  • DOI: 10.1186/s12935-023-02851-8

“Clinical significance of CD166 and HER-2 in different types of gastric cancer”

  • Journal: Clinical and Translational Oncology
  • Publication Date: 2023
  • DOI: 10.1007/s12094-023-03297-0

“COVID-19 pandemic impact on screening and diagnosis of prostate cancer: a systematic review”

  • Journal: BMJ Supportive and Palliative Care
  • Publication Date: 2023
  • DOI: 10.1136/spcare-2023-004310

Conclusion 🏅

Fatemeh Tajik is a highly qualified candidate for the Research for Cancer Biophotonics Award due to her impressive research output, strong academic background, and impactful work in cancer diagnostics. However, to make her application more competitive, she should highlight her direct contributions to biophotonics, expand her involvement in industry collaborations, and clearly outline her most significant scientific innovations.